Compared with the lowest quintile of midlife physical activity, the top two quintiles were associated with 40% lower ...

Alzheon, Inc., a clinical-stage biopharmaceutical company advancing innovative therapeutics and diagnostics for patients with ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after ...

Staring at the ceiling while the clock blinks 3am doesn't only sap energy for the next day. A large, long-running U.S. study of older adults has now linked chronic insomnia to changes inside the brain ...

NewAmsterdam Pharma gains from strong phase 3 obicetrapib results, LDL-C reduction and expansion into diabetes and ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in ...

In April, the future was looking bleak for an experimental Alzheimer's drug called valiltramiprosate, or ALZ-801. Researchers had just released topline results of a study of more than 300 people age ...

NAARDEN, the Netherlands and MIAMI, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam” or the "Company”), a late-stage, clinical biopharmaceutical ...

Memory loss looks like a slow fade, yet the biology behind it can change in a single, stunned heartbeat. This week, a series of human studies landed with a thud on lab benches across the world, ...

An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ...